|
2025
|
P/S
|
Pharmaceutical and medical preparations.
Computer hardware and software for use and in connection... |
|
2024
|
P/S
|
Pharmaceutical preparations for medical purposes; synthetic peptides for pharmaceuticals purposes... |
|
|
P/S
|
Pharmaceutical preparations for medical purposes; synthetic
peptides for pharmaceuticals purpose... |
|
|
P/S
|
Pharmaceutical and medical preparations. Computer hardware and software for use and in connection... |
|
|
Invention
|
Dasiglucagon for use in the treatment of congenital hyperinsulinism. The invention relates to das... |
|
|
P/S
|
Pharmaceutical preparations, namely for treatment of human patients suffering from CHI (Congenita... |
|
|
P/S
|
Pharmaceutical preparations, namely for treatment of human
patients suffering from CHI (Congenit... |
|
|
Invention
|
Amylin analogues.
The present invention relates to amylin analogues and to their use in the trea... |
|
|
Invention
|
Combination therapy. The present invention relates to use of an amylin analogue and a dual agonis... |
|
|
Invention
|
Analogues with improved properties. The present invention relates to therapeutic and non-therapeu... |
|
|
Invention
|
Weight loss. The present invention relates to therapeutic and non-therapeutic methods using pepti... |
|
|
P/S
|
Pharmaceutical preparations, namely for treatment and prevention of stomach and bowel-related dis... |
|
|
Invention
|
Peptide inhibitors of interleukin-23 receptor. The present invention relates to compounds that ar... |
|
|
P/S
|
Pharmaceutical preparations, namely for treatment and
prevention of stomach and bowel-related di... |
|
|
P/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for treatment and prevention of ... |
|
|
Invention
|
Glucagon-like-peptide-2 (glp-2) analogues and their medical uses for the treatment of short bowel... |
|
|
Invention
|
Acylated glucagon analogues.
The invention provides materials and methods for the treatment of o... |
|
2023
|
P/S
|
infusion pumps; medical devices, namely, infusion pumps for subcutaneous delivery of drugs; medic... |
|
|
Invention
|
Inhibitors. The present invention relates to use of inhibitors of the potassium channel Kv1.3 in ... |
|
|
Invention
|
Formulations of glucagon-like-peptide-2 (glp-2) analogues.
Liquid formulations of GLP-2 analogue... |
|
|
Invention
|
Methods for treating obesity. The present invention features methods for treating obesity and pro... |
|
|
Invention
|
Gip agonist compounds and methods.
The present invention relates to acylated GIP analogues which... |
|
|
Invention
|
Glucagon analogues.
The present invention relates to glucagon analogues and their medical use, f... |
|
|
Invention
|
Combination therapy. The present invention relates to therapeutic methods using acylated compound... |
|
|
Invention
|
Cyclic peptides multimers targeting α4β7 integrin. There is described herein, multimers comprisin... |
|
|
Invention
|
Liquid formulations of amylin analogues.
The present invention relates to formulations of amylin... |
|
|
Invention
|
Liquid formulations of amylin analogues. The present invention relates to formulations of amylin ... |
|
|
P/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment or prevention ... |
|
|
P/S
|
Pharmaceutical preparations, namely, pharmaceutical
preparations for the treatment or prevention... |
|
2022
|
Invention
|
Processes for synthesizing glucagon-like-peptide 2 (glp-2) analogues. The present invention relat... |
|
|
Invention
|
Compounds.
Compounds of formula (I):
Compounds of formula (I):
Compounds of formula (I):... |
|
|
Invention
|
Compounds. Compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof, a... |
|
|
Invention
|
Compounds having α4β7 integrin inhibition activity. Compounds of formula (1):
and pharmaceutica... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of human patients suffering from congenital hyperin... |
|
|
P/S
|
Pharmaceuticals, medical and veterinary preparations. Surgical, medical, dental and veterinary ap... |
|
|
Invention
|
Process for formulating compositions comprising glucagon-like-peptide-2 (glp-2) analogues. Proces... |
|
|
Invention
|
Dosage regime.
The invention relates to a dosage regime for compounds having agonist activity at... |
|
|
Invention
|
Dosage regime. The invention relates to a dosage regime for compounds having agonist activity at ... |
|
|
Invention
|
Acylated glp-1/glp-2 dual agonists.
A compound having agonist activity at the GLP-1 (glucagon-li... |
|
|
Invention
|
Kv1.3 blockers.
The present invention provides novel blockers of the potassium channel Kv1.3, po... |
|
|
Invention
|
Kv1.3 blockers. The present invention provides novel blockers of the potassium channel Kv1.3, pol... |
|
|
Invention
|
Composition for treating short bowel syndrome.
The present invention relates to a composition co... |
|
|
Invention
|
Composition for treating short bowel syndrome. The present invention relates to a composition com... |
|
2021
|
Invention
|
Pharmaceutical composition of glp-1/glp-2 dual agonists.
The present invention relates to pharma... |
|
|
Invention
|
Use of glp-2 analogues in patients with renal insufficiency.
The present invention relates to do... |
|
|
P/S
|
printed publications, namely, brochures and newsletters in the fields of pharmaceuticals, financi... |
|
|
Invention
|
Compounds targeting alpha4-beta7 integrin.
Abstract: Compounds of formula (I) and pharmaceutical... |
|
|
Invention
|
Glp-1/glp-2 dual agonists.
The invention relates to a composition comprising a GLP-1/GLP-2 dual ... |
|
|
Invention
|
Agonist combination.
The present invention relates to an agonist combination comprising a GLP-1 ... |
|
2020
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for treating diabetes; chemical preparat... |
|
|
P/S
|
(Based on 44(e)) Pharmaceutical preparations for the treatment of diabetes, obesity and gastroint... |
|
|
Invention
|
Pharmaceutical parenteral composition of dual glp1/2 agonist.
The present invention relates to p... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of hypoglycemia; medical preparation... |
|
|
P/S
|
Pharmaceuticals; pharmaceutical preparations for the treatment of hypoglycaemia; antihypoglycemic... |
|
2019
|
P/S
|
Pharmaceuticals and natural remedies; Pre-filled syringes for medical purposes. Medical and veter... |
|
|
P/S
|
Pharmaceutical, medical and veterinary preparations. Surgical, medical, dental and veterinary app... |
|
2017
|
P/S
|
Biomedical compounds, peptide substrates used in analyzing and detecting certain toxins for clini... |
|
2015
|
P/S
|
Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins f... |
|
|
P/S
|
(Based on Section 44(e)) Biomedical compounds, namely, peptide substrates used in analyzing and d... |
|
2012
|
P/S
|
Medical apparatus, namely, infusion and injection devices for administering insulin. |
|
2009
|
P/S
|
Chemicals used in industry, science and photography, as well as in agriculture, horticulture and ... |
|
2007
|
P/S
|
Biomedical compounds, namely chemicals used in science, laboratory or research; peptide substrate... |
